Search results

1

Specific inhibitors of the

100%

Mirowski M., Wierzbicki R.

Postępy Higieny i Medycyny Doświadczalnej

|

1993

|

vol. 47

|

issue 2

147-157

EN

The article contains a survay of the recent papers on the which regulate the process of - PAI-1 and PAI-2. Both of them belong to serine family and are specific for tPA as well as uPA, forming stable complexes in molar ratio 1 : 1 with them. PAI-1, secreted mainly by and , is the main plasmic inhibitor of plasminogen activation. PAI-2, originated essentially from , appears in during .

2

- new AA-derived molecules

70%

Stajszczyk M., Gaminski J.

Postępy Higieny i Medycyny Doświadczalnej

|

1993

|

vol. 47

|

issue 2

133-145

EN

The paper deals with the current state of knowledge on . The , multiple biosynthesis pathways, possible mechanisms of action, and participation of lipoxins in are characterised.

3

Lipoprotein (a) ? structure, features, physiological and pathological significance

70%

Murawska-Cialowicz E., Poplawska A.

Postępy Higieny i Medycyny Doświadczalnej

|

2003

|

vol. 57

|

issue 3

323-333

EN

The data on the structure and the role of lipoprotein (a) were presented. It posses plasminogene and lipoproteins elements in its structure. Up to now it is not well known the physiological role of lipoprotein (a). There are many proofs in the literature that lipoprotein (a) is an independent coronary risk factor. It is also known as an acute phase protein.

Refine search results

3 Postępy Higieny i Medycyny Doświadczalnej

1 2003

2 1993

1 Gaminski J.

1 Mirowski M.

1 Murawska-Cialowicz E.

1 Poplawska A.

1 Stajszczyk M.

1 Wierzbicki R.

Specific inhibitors of the

- new AA-derived molecules

Lipoprotein (a) ? structure, features, physiological and pathological significance